SCHEMBL6206411

SCHEMBL6206411

CCOc1ccc2[nH]cc(C(=O)NCc3ccc(CN4CCN(c5ncccn5)CC4)cc3)c(=O)c2c1

nearest known ligand 0.67

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
POLB P06746 6/20 0.67
KDM4E B2RXH2 3/20 0.57
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
ALDH1A1 P00352 1/20 0.53
HPGD P15428 1/20 0.53
HSD17B10 Q99714 1/20 0.53
MAPT P10636 5/20 0.53
TP53 P04637 1/20 0.53
TDP1 Q9NUW8 1/20 0.45
ACHE P22303 1/20 0.45
RXFP1 Q9HBX9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6205594 0.90 POLB (0.82) POLBKDM4EMEN1KMT2AALDH1A1
SCHEMBL6205315 0.88 POLB (0.70) POLBKDM4EMEN1KMT2AALDH1A1
SCHEMBL6206611 0.88 POLB (0.73) POLBKDM4EMEN1KMT2AALDH1A1
SCHEMBL6232306 0.88 POLB (0.75) POLBKDM4EMEN1KMT2AALDH1A1
SCHEMBL6227980 0.88 KDM4E (0.73) POLBKDM4EMEN1KMT2AALDH1A1
SCHEMBL6203893 0.88 POLB (0.72) POLBKDM4EMEN1KMT2AALDH1A1
SCHEMBL6205957 0.87 POLB (0.64) POLBKDM4EMEN1KMT2AALDH1A1
SCHEMBL6205316 0.87 POLB (0.68) POLBKDM4EMEN1KMT2AALDH1A1
SCHEMBL6205266 0.87 POLB (0.70) POLBKDM4EMEN1KMT2AALDH1A1
SCHEMBL6203683 0.87 POLB (0.63) POLBKDM4EMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177177-B1 SUBSTITUTED 4-OXO-QUINOLINE-3-CARBOXAMIDES: GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-02-23 EP claimed
US-6413956-B1 AGONISTS, ANTAGONISTS OR INVERSE AGONISTS AND LOCALIZATION PROBES FOR GAMMA AMINOBUTYRIC ACID BRAIN RECEPTORS; ANXIETY, DEPRESSION, DOWN SYNDROME, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND MEMORY ENHANCEMENT NEUROGEN CORPORATION 2002-07-02 US claimed